1. Home
  2. HELE vs ORKA Comparison

HELE vs ORKA Comparison

Compare HELE & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HELE
  • ORKA
  • Stock Information
  • Founded
  • HELE 1968
  • ORKA 2004
  • Country
  • HELE United States
  • ORKA United States
  • Employees
  • HELE N/A
  • ORKA N/A
  • Industry
  • HELE Home Furnishings
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HELE Consumer Discretionary
  • ORKA Health Care
  • Exchange
  • HELE Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • HELE 505.7M
  • ORKA 580.3M
  • IPO Year
  • HELE N/A
  • ORKA N/A
  • Fundamental
  • Price
  • HELE $22.92
  • ORKA $16.21
  • Analyst Decision
  • HELE Hold
  • ORKA Strong Buy
  • Analyst Count
  • HELE 3
  • ORKA 6
  • Target Price
  • HELE $44.33
  • ORKA $40.83
  • AVG Volume (30 Days)
  • HELE 665.5K
  • ORKA 190.4K
  • Earning Date
  • HELE 10-08-2025
  • ORKA 11-12-2025
  • Dividend Yield
  • HELE N/A
  • ORKA N/A
  • EPS Growth
  • HELE N/A
  • ORKA N/A
  • EPS
  • HELE N/A
  • ORKA N/A
  • Revenue
  • HELE $1,862,473,000.00
  • ORKA N/A
  • Revenue This Year
  • HELE N/A
  • ORKA N/A
  • Revenue Next Year
  • HELE $3.12
  • ORKA N/A
  • P/E Ratio
  • HELE N/A
  • ORKA N/A
  • Revenue Growth
  • HELE N/A
  • ORKA N/A
  • 52 Week Low
  • HELE $20.02
  • ORKA $5.49
  • 52 Week High
  • HELE $77.95
  • ORKA $31.13
  • Technical
  • Relative Strength Index (RSI)
  • HELE 41.71
  • ORKA 57.56
  • Support Level
  • HELE $23.10
  • ORKA $14.67
  • Resistance Level
  • HELE $24.86
  • ORKA $16.21
  • Average True Range (ATR)
  • HELE 1.11
  • ORKA 1.09
  • MACD
  • HELE -0.19
  • ORKA -0.04
  • Stochastic Oscillator
  • HELE 3.26
  • ORKA 41.13

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: